Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 337 | nsp13:R337C; | CL-3e; |
| 339 | nsp13:R339H; | CL-3d; |
| 339 | nsp13:R339S; | CL-3f; |
| 392 | nsp13:R392-; | CL-1b;CL-3b;CL-3e;CL-3f; |
| 392 | nsp13:R392H; | CL-1a_3d;CL-3f;CL-5; |
| 392 | nsp13:R392L; | CL-3b;CL-3c;CL-3d;CL-3f; |
| 392 | nsp13:R392S; | CL-3d; |
| 409 | nsp13:R409-; | CL-3b;CL-3e; |
| 427 | nsp13:R427I; | CL-3e; |
| 442 | nsp13:R442-; | CL-3b;CL-3e; |
| 442 | nsp13:R442L; | CL-3d; |
| 442 | nsp13:R442W; | CL-3b; |
| 490 | nsp13:R490-; | CL-3b; |
| 502 | nsp13:R502-; | CL-3b; |
| 502 | nsp13:R502C; | CL-3b;CL-3c;CL-3e; |
| 502 | nsp13:R502L; | CL-3b; |
| 507 | nsp13:R507-; | CL-5; |
| 507 | nsp13:R507G; | CL-3e; |
| 507 | nsp13:R507K; | CL-3b; |
| 560 | nsp13:R560-; | CL-3b; |
| 579 | nsp13:R579I; | CL-3b; |
| 579 | nsp13:R579K; | CL-3b;CL-3e; |
| 579 | nsp13:R579S; | CL-3c; |
| 594 | nsp13:R594-; | CL-3d;CL-3e; |
| 595 | nsp13:R595G; | CL-3d; |
| 595 | nsp13:R595K; | CL-3d;CL-3e;CL-3f; |
| 595 | nsp13:R595S; | CL-3e; |
| 100 | nsp13:S100-; | CL-3d; |
| 100 | nsp13:S100I; | CL-5; |
| 10 | nsp13:S10A; | CL-3d; |
| 166 | nsp13:S166-; | CL-3b;CL-3c;CL-3e;CL-3f; |
| 166 | nsp13:S166A; | CL-1a; |
| 236 | nsp13:S236-; | CL-3b;CL-3d;CL-3e; |
| 263 | nsp13:S263-; | CL-3b; |
| 263 | nsp13:S263P; | CL-3b;CL-3d; |
| 278 | nsp13:S278-; | CL-3b; |
| 278 | nsp13:S278F; | CL-1a_3d;CL-1b;CL-3b;CL-3d;CL-5; |
| 278 | nsp13:S278Y; | CL-3c; |
| 301 | nsp13:S301-; | CL-3b; |
| 301 | nsp13:S301Y; | CL-3e;CL-3f; |
| 310 | nsp13:S310-; | CL-3e; |
| 310 | nsp13:S310A; | CL-3b; |
| 36 | nsp13:S36A; | CL-3c; |
| 36 | nsp13:S36P; | CL-3b;CL-3f; |
| 377 | nsp13:S377-; | CL-3b; |
| 38 | nsp13:S38-; | CL-1a_3e;CL-1b;CL-3b;CL-3e; |
| 38 | nsp13:S38P; | CL-3d;CL-3e; |
| 424 | nsp13:S424-; | CL-3e;CL-4; |
| 44 | nsp13:S44-; | CL-3c;CL-3d; |
| 468 | nsp13:S468-; | CL-1a_3e;CL-3b;CL-3e; |
Page 184 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com